Robert Delage

Starkman R, Alibhai S, Wells RA, Geddes M, Zhu N, Keating MM, Leber B, Chodirker L, Sabloff M, Christou G, Leitch HA, St-Hilaire E, Finn N, Shamy A, Yee K, Storring J, Nevill T, Delage R, Elemary M, Banerji V, Lenis M, Kirubananthaan A, Mamedov A, Zhang L, Rockwood K, Buckstein R

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Leukemia, 34 (5), 2020.

Résumé | Liens:

Wan BA, Nazha A, Starkman R, Alibhai S, Wells RA, Geddes M, Zhu N, Keating MM, Leber B, Chodirker L, Sabloff M, Christou G, Leitch HA, St-Hilaire E, Finn N, Shamy A, Yee KWL, Storring J, Nevill TJ, Delage R, Elemary M, Banerji V, Parmentier A, Siddiqui M, Kirubananthaan A, Mamedov A, Zhang L, Buckstein R

Revised 15-item MDS-specific frailty scale maintains prognostic potential

Leukemia, 34 (12), 2020.

| Liens:

Klil-Drori AJ, Yin H, Azoulay L, Del Corpo A, Harnois M, Gratton MO, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE,

Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia

Cancer, 125 (4), 2019.

Résumé | Liens:

Leitch HA, Buckstein R, Zhu N, Nevill TJ, Yee KWL, Leber B, Keating MM, St Hilaire E, Kumar R, Delage R, Geddes M, Storring JM, Shamy A, Elemary M, Wells RA

Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS

Leuk Res, 74 , 2018.

Résumé | Liens:

Leitch HA, Parmar A, Wells RA, Chodirker L, Zhu N, Nevill TJ, Yee KWL, Leber B, Keating MM, Sabloff M, St Hilaire E, Kumar R, Delage R, Geddes M, Storring JM, Kew A, Shamy A, Elemary M, Lenis M, Mamedov A, Ivo J, Francis J, Zhang L, Buckstein R

Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis

Br J Haematol, 179 (1), 2017.

Résumé | Liens:

Houston BL, Jayakar J, Wells RA, Lenis M, Zhang L, Zhu N, Leitch HA, Nevill TJ, Yee KWL, Leber B, Sabloff M, St-Hilaire E, Kumar R, Geddes M, Shamy A, Storring JM, Keating MM, Elemary M, Delage R, Mamedov A, Buckstein R

A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

Ann Hematol, 96 (12), 2017.

Résumé | Liens:

Shustik C, Bence-Bruckler I, Delage R, Owen CJ, Toze CL, Coutre S

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

Ann Hematol, 96 (7), 2017.

Résumé | Liens:

Klil-Drori AJ, Yin H, Azoulay L, Harnois M, Gratton MO, Del Corpo A, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE,

Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response

Am J Hematol, 92 (10), 2017.

| Liens:

Dugas-Bourdages E, Neron S, Roy A, Darveau A, Delage R

Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction

Adv Hematol, 2014 , 2014.

Résumé | Liens:

Siegloch K, Schmitz N, Wu HS, Friedrichs B, van Imhoff GW, Montoto S, Holler E, Ribera JM, Delage R, Duhrsen U, Castillo ND, Harrison B, Dreger P, Sureda A,

Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report

Biol Blood Marrow Transplant, 19 (10), 2013.

Résumé | Liens: